Merus N.V.
CIK:
0001651311
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
Netherlands
Business Address
YALELAAN 62, 3584 CM UTRECHT, DE,
Mailing Address
YALELAAN 62, 3584 CM UTRECHT, DE,
Phone
31 030 253 8800
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2024
$782.69M
Total Assets
$134.77M
Total Liabilities
$293.29M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 8-K Current report of material events | December 30, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | December 19, 2025 | View on SEC |
| 3 Initial insider ownership report | December 18, 2025 | View on SEC |
| 4 Insider stock transaction report | December 18, 2025 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
Material Events
8-K
Acquisition
December 30, 2025
High Impact
- Merus N.V. has been acquired by Genmab A/S through its subsidiary.
- Genmab bought almost all of Merus's common shares for $97.00 each in cash.
8-K
Acquisition
December 12, 2025
High Impact
- Merus N.V. has been acquired by Genmab A/S through one of its subsidiaries.
- Genmab purchased almost all of Merus's shares for $97.00 per share in cash.
8-K
Acquisition
December 9, 2025
High Impact
- Merus N.V. shareholders approved proposals related to the company's acquisition by Genmab A/S.
- Genmab A/S is acquiring all of Merus's outstanding shares for $97.00 per share in cash.
Insider Trading
STRONG BUY
2 insiders
13 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
NERVGEN PHARMA CORP.
NGEN
Pharmaceutical Preparations
Connect Biopharma Holdings Ltd
CNTB
Pharmaceutical Preparations
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXT
Pharmaceutical Preparations
TuHURA Biosciences, Inc./NV
HURA
Pharmaceutical Preparations
Canton Strategic Holdings, Inc.
CNTN
Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.